MRCM
MED icon

Mill Road Capital Management’s Medifast MED Stock Holding History

Mill Road Capital Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-167,600
Closed -$32.9M – 27
2020
Q4 		$32.9M Buy
+167,600
New +$29.6M 11.63% 4

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Mill Road Capital Management's MED Position: Q1 2021 in Review

Mill Road Capital Management sold out of Medifast (MED) in Q1 2021, closing a stake of 172,449 shares — an estimated $33.9M sold.

Mill Road Capital Management first reported a position in MED in Q4 2020 and held it in 1 quarter. The position peaked at $33.9M in Q4 2020. 277 funds tracked by Wall St. Rank hold MED as of Q1 2021.

  • Mill Road Capital Management reported no remaining Medifast position as of Q1 2021 after selling out during the quarter.
  • Mill Road Capital Management sold 172,449 Medifast shares in Q1 2021, an estimated $33.9M.
  • Mill Road Capital Management first reported a position in Medifast in Q4 2020 and held it in 1 quarter.
  • Mill Road Capital Management's Medifast position peaked at $33.9M in Q4 2020.
  • 277 funds tracked by Wall St. Rank held Medifast as of Q1 2021.

Based on Mill Road Capital Management's 13F filing for Q1 2021, filed 17 May 2021.